The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.00
Bid: 44.10
Ask: 45.90
Change: 0.00 (0.00%)
Spread: 1.80 (4.082%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 45.00
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Share Options and Issue of Shares

9 Mar 2017 08:44

RNS Number : 9750Y
Benchmark Holdings PLC
09 March 2017
 

9 March 2017

 

BENCHMARK HOLDINGS PLC("Benchmark" or the "Company" or the "Group")

 

DIRECTOR SHARE OPTIONS AND ISSUE OF SHARES

 

Director share options 

 

Benchmark Holdings plc announces that on 6 March 2017, and in accordance with the intention disclosed in its Annual Report and Accounts published on 24 January 2017, options over a total of 56,938 Ordinary Shares of 0.1 pence each ("Ordinary Shares") were granted to Mark Plampin, the Company's Chief Financial Officer under the Company Share Option Plan (CSOP) in respect of the 2016 deferred bonus. Following this grant, Mark Plampin remains interested in 536,686 Ordinary Shares and holds options over a total of 124,585 Ordinary Shares in the Company, representing approximately 0.1% and 0.02% of Benchmark's existing issued share capital respectively.

 

The options granted have a vesting period of three years, may be exercised up to the tenth anniversary of grant, have an exercise price of 0.1 pence per Ordinary Share and are not subject to performance criteria.

 

Notification and public disclosure of a transaction by a person discharging managerial responsibilities: 

 

Details of the person discharging managerial responsibilities / person closely associated 

 

a) 

 

Name 

 

Mark Plampin

 

Reason for the notification 

 

a) 

 

Position/status 

 

Executive Director

b) 

 

Initial notification/Amendment 

 

Initial

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

 

a) 

 

Name

 

Benchmark Holdings plc

b) 

 

LEI 

n/a

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) 

 

Description of the financial instrument, type of instrument 

Identification code 

 

0.1p ordinary shares

ISIN: GB00BGHPT808 

b) 

 

Nature of the transaction 

 

Issue of share options under Company Share Option Plan (CSOP)

c) 

 

Price(s) and volume(s) 

 

 

Exercise price

 

Volume(s)

0.1p

56,938

d) 

 

Aggregated information

- Aggregated volume 

- Price 

 

Volume: 56,938

Price: Nil

e) 

 

Date of the transaction 

 

6 March 2017

f) 

 

Place of the transaction 

 

AIM Market, London Stock Exchange

 

 

Issue of shares and admission to trading

 

In addition, the Company announces that application has been made for the admission to trading of 25,811 Ordinary Shares pursuant to the exercise of employee options under its Employee Global Share Incentive Plan (SIP).

 

Application has been made for these shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective at 8.00 a.m. on 13 March 2017 and that dealings in the shares will commence at that time.

 

The Company's total issued share capital following the issue of the shares pursuant to the Global SIP will consist of 522,247,168 ordinary shares of 0.1 pence each with one voting right per share. The above figure of 522,247,168 may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company following Admission.

 

-Ends-

 

For further information, please contact:

 

Benchmark Holdings plc

Tel: 020 7920 3150

Malcolm Pye, CEO

Roland Bonney, COO

Rachel Aninakwah, Communications

Numis

Tel: 020 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)

James Black (Corporate Broking)

Tavistock

Tel: 020 7920 3150

Niall Walsh / Sophie Praill

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHJLMPTMBIMMJR
Date   Source Headline
6th Nov 20177:00 amRNSDirectorate Change
30th Oct 20177:00 amRNSLand-based Broodstock Facility Reaches Milestone
17th Oct 20177:00 amRNSNew Vaccine Facility Delivers First Production
10th Oct 20172:41 pmRNSHolding(s) in Company
21st Sep 20177:00 amRNSBlock Listing Six Monthly Return
8th Sep 20177:00 amRNSTrading Update
22nd Aug 20177:00 amRNSRenewal of Sales and Marketing Agreement
16th Aug 20177:00 amRNSLaunch of breakthrough purification system
28th Jul 20172:57 pmRNSDirector leave of absence
27th Jun 20177:02 amRNSHalf-year Report
19th Jun 20173:00 pmRNSNotice of Results
25th May 20177:00 amRNSTrading Update and Notice of Results
2nd May 20177:00 amRNSTotal Voting Rights
26th Apr 201710:54 amRNSDirector Dealings
3rd Apr 20174:32 pmRNSBlock Listing Six Monthly Return
9th Mar 20178:44 amRNSDirector Share Options and Issue of Shares
7th Mar 201710:39 amRNSResult of AGM
7th Mar 20178:00 amRNSContract Win
2nd Mar 20173:34 pmRNSHolding(s) in Company
1st Mar 20172:09 pmRNSHolding(s) in Company
23rd Feb 20177:00 amRNSHolding(s) in Company
22nd Feb 20174:35 pmRNSHolding(s) in Company
16th Feb 20177:45 amRNSDirector Dealings
24th Jan 20177:00 amRNSFinal Results
3rd Jan 20177:00 amRNSTotal Voting Rights
1st Dec 20167:00 amRNSDirector/PDMR Shareholding
29th Nov 20167:00 amRNSCapital Markets Day
25th Nov 20167:00 amRNSAppointment of Non-Executive Director
23rd Nov 20164:52 pmRNSHolding(s) in Company
26th Oct 20167:00 amRNSTrading Statement
12th Oct 20167:00 amRNSBlock Admission Application
10th Oct 201612:02 pmRNSBlock listing Interim Review
31st Aug 20167:00 amRNSBenchmark secures innovative new equine vaccine
12th Aug 201612:41 pmRNSHolding(s) in Company
11th Aug 20167:00 amRNSAcq of South American shrimp breeding programme
10th Aug 20163:37 pmRNSHolding(s) in Company
10th Aug 20161:40 pmRNSHolding(s) in Company
10th Aug 20161:33 pmRNSHolding(s) in Company
10th Aug 20161:29 pmRNSHolding(s) in Company
9th Aug 20163:26 pmRNSHolding(s) in Company
5th Aug 20167:00 amRNSPlacing of 47.3 million new ordinary shares
29th Jul 20167:00 amRNSDirectorate Change
19th Jul 20167:00 amRNSNew Seabass Vaccine Commences Field Trials
12th Jul 20167:00 amRNSBreeding & Genetics Contract Win
28th Jun 20167:00 amRNSHalf-year Report
3rd Jun 20167:00 amRNSChange of Adviser
27th May 20167:00 amRNSChange of Auditor
26th May 20167:00 amRNSTrading Update and Notice of Results
22nd Apr 201610:45 amRNSHolding(s) in Company
18th Apr 20169:40 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.